Cancers, Vol. 16, Pages 1411: Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer & mdash;Evidence from a 17-Year Follow-Up Study

Conclusions: In premenopausal women at risk of early-stage breast cancer, PCSK9 did not appear to have a role as a prognostic biomarker of breast neoplastic events. Larger studies are warranted investigating patients in different settings.

Source: Cancers - April 4, 2024 Category: Cancer & Oncology Authors: Massimiliano Ruscica Chiara Macchi Sara Gandini Debora Macis Aliana Guerrieri-Gonzaga Valentina Aristarco Davide Serrano Matteo Lazzeroni Alessandra Stefania Rizzuto Aurora Gaeta Alberto Corsini Marcella Gulisano Harriet Johansson Bernardo Bonanni Tags: Article Source Type: research